Extracellular vesicles study in CAR-T cell therapy patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at tiny particles called extracellular vesicles in the blood of people receiving CAR-T cell therapy for certain blood cancers. It may help researchers understand how these particles affect treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a blood cancer like certain types of lymphoma, leukemia, or multiple myeloma that has come back or not responded to treatment
- You are scheduled to receive or have already received a CAR-T cell therapy product
- You are 18 years old or older
- You agree to sign a consent form to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.
This study will look at information from people with non-Hodgkin lymphoma who are getting CAR-T cell therapy (a treatment that uses your own immune cells to attack cancer). The goal is to create tools that help doctors predict how well the treatment will work and what side effects might happen, so they can better care for patients.
This study is for people getting CAR-T cell therapy, a type of cancer treatment that uses your own immune cells. Researchers want to understand a rare side effect called neurotoxicity by looking at tiny particles in your blood called extracellular vesicles.
This study looks at how your immune system responds to CAR-T cell therapy, a treatment that uses your own immune cells to fight certain cancers. By participating, you help researchers learn more about how this therapy affects the body, which could improve care for future patients.
This study is for people with blood cancers who are treated with CAR-T cell therapy. Researchers will follow participants over time to learn more about how this therapy works in the real world.
This study looks at how well CAR-T cell therapy—a treatment that uses your own immune cells to fight cancer—works for people with certain blood cancers like lymphoma, acute lymphoblastic leukemia, or multiple myeloma. The goal is to see if the characteristics of the tumor affect how well the treatment works.
Hear when a new CAR-T Cell Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.